NRS
Live / Applied — Third extension granted (statement of use) (as of 17 Dec 2025)
What this means for you
Not registered yet, but its 19 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97896480
- Mark type
- Stylized text
- Filed
- 19 Apr 2023
- Published for opposition
- 20 Feb 2024
- Attorney of record
- Cheryl A. Withycombe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neuropsychological diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the field of neuroscience
Owner
- Cerevel Therapeutics, LLC, North Chicago, IL, US
- Cerevel Therapeutics, LLC, Cambridge, MA, US
Prosecution history
- 18 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2025 — SOU EXTENSION 3 GRANTED
- 15 Oct 2025 — SOU EXTENSION 3 FILED
- 15 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Oct 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 20 Oct 2025 — NOTICE OF REVIVAL - E-MAILED
- 20 Oct 2025 — PETITION TO REVIVE-GRANTED
- 20 Oct 2025 — TEAS PETITION TO REVIVE RECEIVED
- 01 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2025 — SOU EXTENSION 2 GRANTED
- 31 Mar 2025 — SOU EXTENSION 2 FILED
- 31 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Oct 2024 — SOU EXTENSION 1 GRANTED
- 14 Oct 2024 — SOU EXTENSION 1 FILED